Dural Adhesive Agent for Surgical Market to Grow at 5.29% CAGR through 2029F

Growing preference for minimally invasive procedures and expansion of healthcare infrastructure in emerging economies is expected to drive the Global Dural Adhesive Agent for Surgical Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “Dural Adhesive Agent for Surgical Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, the Global Dural Adhesive Agent for Surgical Market was valued at USD 186.89 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.29% through 2029.

Advancements in biomaterials and biotechnology are driving a paradigm shift in the development of dural adhesive agents, offering unprecedented opportunities to enhance surgical outcomes and patient care. Manufacturers are at the forefront of this revolution, leveraging cutting-edge research and innovation to engineer next-generation adhesive formulations with superior properties. One of the key areas of focus is the enhancement of biocompatibility, ensuring that dural adhesive agents interact seamlessly with the body's tissues without triggering adverse reactions. By harnessing biomaterials such as bioresorbable polymers, researchers can design adhesive formulations that degrade over time, eliminating the need for surgical removal and reducing the risk of long-term complications. These bioresorbable materials mimic the properties of native tissues, promoting natural healing processes and minimizing foreign body responses.

In addition to biocompatibility, manufacturers are prioritizing improvements in adhesive strength and tissue integration properties. Through advances in nanotechnology, researchers can manipulate materials at the molecular level, enhancing adhesive bonding and durability. Nanomaterials offer unique mechanical properties and surface characteristics, allowing for strong and durable adhesion to dural tissues while minimizing tissue trauma and inflammation.

The integration of bioactive compounds and growth factors into adhesive formulations represents a groundbreaking approach to enhancing the therapeutic potential of dural adhesive agents. By incorporating factors such as platelet-rich plasma (PRP), stem cells, or neurotrophic factors, manufacturers can promote tissue regeneration, angiogenesis, and neuroprotection at the site of application. These bioactive additives not only facilitate wound healing but also support neuronal survival and function, offering potential benefits for patients undergoing neurosurgical procedures.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Dural Adhesive Agent for Surgical Market”

The Global Dural Adhesive Agent for Surgical Market is segmented into application, type, form, regional distribution, and company.

Based on form, In 2023, the sealant glue segment emerged as the dominant segment in the global dural adhesive agent for surgical market. This dominance can be attributed to several key factors that highlight the unique advantages of sealant glue formulations in neurosurgical applications. Sealant glue offers a versatile and effective solution for dural closure and sealing in a variety of neurosurgical procedures. Its liquid or semi-liquid form allows for easy application to the surgical site, enabling surgeons to achieve secure dural closure with minimal tissue manipulation. This is particularly advantageous in cranial and spinal surgeries where precision and delicacy are paramount to minimize the risk of tissue trauma and postoperative complications.

Sealant glue formulations typically exhibit strong adhesive properties, forming a durable bond between tissue surfaces and providing effective hemostasis. This ensures reliable dural closure and reduces the risk of cerebrospinal fluid leakage, a common complication in neurosurgical procedures. Sealant glue can conform to irregular tissue contours and fill small gaps or defects, enhancing its effectiveness in achieving watertight dural closure. Sealant glue formulations offer flexibility in application, allowing surgeons to tailor the consistency and viscosity of the adhesive to suit specific surgical requirements. Whether applied as a liquid, gel, or foam, sealant glue can accommodate various surgical techniques and approaches, including minimally invasive procedures and complex cranial reconstructions.

Based on region, the Asia Pacific region is anticipated to be the fastest-growing in the forecast period in the global dural adhesive agent for surgical market. Several factors contribute to this anticipated growth, including increasing healthcare expenditure, rising adoption of advanced surgical techniques, and expanding access to neurosurgical interventions across emerging economies in the region. In recent years, countries such as China, India, and Japan have witnessed significant investments in healthcare infrastructure, coupled with efforts to enhance medical education and training. This has led to a surge in the number of skilled healthcare professionals and specialized neurosurgical centers capable of performing complex procedures requiring dural adhesive agents.

The Asia Pacific region is experiencing a demographic shift characterized by aging populations and a rising prevalence of neurological disorders. As the burden of these conditions continues to escalate, there is a growing demand for neurosurgical interventions and adjunctive products like dural adhesive agents to improve patient outcomes.

Major companies operating in Global Dural Adhesive Agent for Surgical Market are:

• Medprin Biotech GmbH
• Integra LifeSciences Corporation
• Pramand LLC
• Stryker Corporation
• DuraStat, Inc.
• Medtronic plc
• Becton, Dickinson and Company
• Regenity Biosciences
• Baxter International, Inc.
• Johnson & Johnson 

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Emerging economies are witnessing significant investments in healthcare infrastructure, driven by factors such as economic growth, urbanization, and increasing healthcare expenditure. As healthcare facilities become more advanced and accessible, the demand for neurosurgical procedures, including those requiring dural adhesive agents, is expected to rise. The expansion of healthcare coverage and the increasing adoption of advanced medical technologies in emerging markets are creating lucrative opportunities for market players to expand their presence and tap into previously underserved regions. By enabling surgeons to achieve secure dural closure, these agents contribute to better surgical outcomes, reduced morbidity, and improved patient satisfaction”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Dural Adhesive Agent for Surgical Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Cranial Surgery, Spinal Surgery), By Type (Polyethylene glycol, Others (Fibrin Glue)), By Form (Sealant Glue, Sealant Film) ,By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Dural Adhesive Agent for Surgical Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Dural Adhesive Agent for Surgical Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com